# Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

> **NCT00871403** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 107 (actual)

## Conditions studied

- Lung Cancer, Non-Small Cell

## Interventions

- **DRUG:** pazopanib and pemetrexed
- **DRUG:** pemetrexed and cisplatin

## Key facts

- **NCT ID:** NCT00871403
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2013-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871403, "Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00871403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*